Modeled after the Human Genome Project, which has transformed biomedical research, the Human Vaccines Project seeks to transform how we fight our most devastating diseases by unlocking the mechanisms of human immunity—accelerating the development of new vaccines, diagnostics, and treatments.
To that end, the organization is inviting applications for the Michelson Prizes: Next Generation Grants. Through the program, $150,000 grants will be awarded to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
The committee seeks research to tackle the current roadblocks in human vaccine development and expand our limited understanding of key immune processes fundamental to the successful vaccine and immunotherapy development. The prize will support highly innovative and impactful research, with the potential to be applied across many diseases.
Applications are encouraged from the full spectrum of scientific disciplines related to immunology, vaccine, and immunotherapy research, including but not limited to clinical research, molecular biology, computer science, biophysics, bioengineering, environmental health, biochemistry, protein engineering, AI/machine learning, nanotechnology, microbiome, vector biology.
Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible. Applicants must be employed by or affiliated with an eligible organization (e.g., academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes). Applicants must be age 35 or younger at the time of submission.
Please contact Lynn Wong if you are interested in applying to this opportunity.